Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lo Fermo

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Negative prognostic impact of MRI spinal lesions in the early stages of relapsing-remitting multiple sclerosisE D'Amico, F Patti, C Leone, et al.
Acta Neurologica Scandinavica|April 16, 2014
Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamideF Patti, S Messina, E D'Amico, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 29, 2015
Looks can be deceiving: three cases of neurological diseases mimicking Guillain-Barrè syndromeG Sciacca, A Nicoletti, S Lo Fermo, et al.
Neurotoxicity Research|April 23, 2009
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugsA R Bentivoglio, A Fasano, T Ialongo, et al.
European Journal of Neurology|April 15, 2009
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasmA R Bentivoglio, A Fasano, T Ialongo, et al.
Expert Review of Clinical Pharmacology|March 10, 2018
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experienceE D'Amico, F Patti, A Zanghì, et al.
European Journal of Neurology|June 30, 2018
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up studyE D'Amico, F Patti, A Zanghì, et al.
Neurology|October 26, 2005
Possible increasing risk of multiple sclerosis in Catania, SicilyA Nicoletti, F Patti, S Lo Fermo, et al.
Acta Neurologica Scandinavica|June 9, 2011
Frequency and severity of headache is worsened by Interferon-β therapy in patients with multiple sclerosisF Patti, A Nicoletti, A Pappalardo, et al.
Journal of Neurology|August 5, 2008
Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?F Patti, T Cavallaro, S Lo Fermo, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Negative prognostic impact of MRI spinal lesions in the early stages of relapsing-remitting multiple sclerosisE D'Amico, F Patti, C Leone, et al.
Acta Neurologica Scandinavica|April 16, 2014
Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamideF Patti, S Messina, E D'Amico, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 29, 2015
Looks can be deceiving: three cases of neurological diseases mimicking Guillain-Barrè syndromeG Sciacca, A Nicoletti, S Lo Fermo, et al.
Neurotoxicity Research|April 23, 2009
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugsA R Bentivoglio, A Fasano, T Ialongo, et al.
European Journal of Neurology|April 15, 2009
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasmA R Bentivoglio, A Fasano, T Ialongo, et al.
Expert Review of Clinical Pharmacology|March 10, 2018
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experienceE D'Amico, F Patti, A Zanghì, et al.
European Journal of Neurology|June 30, 2018
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up studyE D'Amico, F Patti, A Zanghì, et al.
Neurology|October 26, 2005
Possible increasing risk of multiple sclerosis in Catania, SicilyA Nicoletti, F Patti, S Lo Fermo, et al.
Acta Neurologica Scandinavica|June 9, 2011
Frequency and severity of headache is worsened by Interferon-β therapy in patients with multiple sclerosisF Patti, A Nicoletti, A Pappalardo, et al.
Journal of Neurology|August 5, 2008
Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?F Patti, T Cavallaro, S Lo Fermo, et al.
Pageof 2